Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OncoImmune Inc.
DescriptionDNA intercalating cyclic peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myeloid leukemia (AML)
Regulatory Designation U.S. - Orphan Drug (Treat acute myeloid leukemia (AML))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today